首页> 外文学位 >Analysis of cell culture models of mammary drug transport.
【24h】

Analysis of cell culture models of mammary drug transport.

机译:乳腺癌药物运输的细胞培养模型分析。

获取原文
获取原文并翻译 | 示例

摘要

A human-derived, mammary epithelial cell culture model would allow drug transport in the mammary epithelium to be studied in greater detail while minimizing risks to mothers and nursing infants. MCF10A and primary human mammary epithelial cells (HMECs) were investigated for their utility as human, cell-based model systems for drug transport studies. Polarized monolayers are essential for transcellular flux studies of drug transporter function, and their formation was measured by transepithelial electrical resistance, immunofluorescence microscopy and vectoral flux studies. Both cell types failed to form adequately polarized monolayers despite various modifications to the cells or culture conditions.;Transporter-mediated drug uptake and efflux in MCF10A cells was measured using flow cytometry, a technique which enables the measurement of intracellular drug concentrations. The fluorescent drug, mitoxantrone, was used to assess active efflux transport by the ABC transporters ABCG2 (BCRP) and ABCB1 (MDR1). After accounting for the inter-day variability with a linear mixed effects model, inhibitor effects on intracellular drug concentrations were evident. Specific inhibition of MDR1 using verapamil increased mitoxantrone accumulation as expected; however, BCRP-specific inhibition with fumitremorgin C decreased accumulation. Flow cytometry studies on mitoxantrone uptake suggested that it is a substrate for an unidentified active uptake transporter.;PEPT1 and PEPT2 transporter functionality in MCF10A cells was evaluated using a fluorescently labeled dipeptide (A-K-AMCA). A-K-AMCA uptake showed an active component which was inhibited by a general metabolic inhibitor, the dipeptide Gly-Gln, and the peptidomimetic cefadroxil, indicating the involvement of a peptide transporter in A-K-AMCA uptake.;Drug transporter expression levels in MCF10A cells and HMECs were measured using RT-PCR. Transporter expression levels, which were similar in the MCF10A cells and the HMECs, were compared with expression levels in lactating and non-lactating mammary epithelial cells. Low expression of BCRP, MDR1 and PEPT1 was seen in MCF10A cells, yet the effects of these transporters could still be observed in functional flow cytometry transport assays. Flow cytometry studies MCF10A cells may useful as a mammary drug transport model for transporters which have similar expression levels to lactating mammary epithelial cells.
机译:通过人类衍生的乳腺上皮细胞培养模型,可以更详细地研究乳腺上皮中的药物运输,同时最大程度地降低对母亲和婴儿的风险。研究了MCF10A和原代人乳腺上皮细胞(HMEC)作为基于人细胞的药物转运研究模型系统的实用性。极化的单层对于药物转运蛋白功能的跨细胞通量研究是必不可少的,其形成是通过跨上皮电阻,免疫荧光显微镜和矢量通量研究来测量的。尽管对细胞或培养条件进行了各种修改,两种细胞类型均未形成足够极化的单层膜。使用流式细胞术测量了MCF10A细胞中转运蛋白介导的药物吸收和流出,该技术可测量细胞内药物浓度。荧光药物米托蒽醌用于评估ABC转运蛋白ABCG2(BCRP)和ABCB1(MDR1)的主动外排转运。用线性混合效应模型考虑日间变化后,抑制剂对细胞内药物浓度的影响显而易见。如预期的那样,使用维拉帕米对MDR1的特异性抑制可增加米托蒽醌的积累;但是,用泛黄霉素C进行的BCRP特异性抑制作用会减少积累。关于米托蒽醌摄取的流式细胞术研究表明,它是未确定的活性摄取转运蛋白的底物。使用荧光标记的二肽(A-K-AMCA)评估了MCF10A细胞中的PEPT1和PEPT2转运蛋白功能。 AK-AMCA的摄取显示出一种活性成分,该活性成分被一般的代谢抑制剂,二肽Gly-Gln和拟肽的头孢羟氨苄抑制,表明肽转运蛋白参与了AK-AMCA的吸收; MCF10A细胞中药物转运蛋白的表达水平和使用RT-PCR测量HMEC。将在MCF10A细胞和HMEC中相似的转运蛋白表达水平与在泌乳和非泌乳的乳腺上皮细胞中的表达水平进行了比较。在MCF10A细胞中观察到BCRP,MDR1和PEPT1的低表达,但仍可以在功能流式细胞术转运测定中观察到这些转运蛋白的作用。流式细胞术研究MCF10A细胞可以用作表达水平与泌乳性乳腺上皮细胞相似的转运蛋白的乳腺药物转运模型。

著录项

  • 作者

    Reiland, Joanne Elizabeth.;

  • 作者单位

    The University of Iowa.;

  • 授予单位 The University of Iowa.;
  • 学科 Health Sciences Pharmacology.
  • 学位 Ph.D.
  • 年度 2009
  • 页码 270 p.
  • 总页数 270
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号